Literature DB >> 27335030

Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease.

Ming Ying1, Xiaojing Sui2, Yanling Zhang2, Qian Sun2, Zhongsen Qu3, Xiaobin Luo4,5, Raymond Chuen-Chung Chang6, Jiazuan Ni1, Jianjun Liu2, Xifei Yang7.   

Abstract

The molecular mechanisms underlying cognitive impairment in Alzheimer's disease (AD) remain largely unclear. In the present study, we were aimed to identify the potential key molecules involved in spatial memory impairment in a triple transgenic (3xTg-AD) mouse model of AD. By employing two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) coupled with mass spectrometry, we revealed a total of 24 differentially expressed proteins in hippocampus of 9-month-old 3xTg-AD mice with significant spatial memory impairment in comparison to the age-matched controls. These differentially expressed proteins can be categorized into several functional classifications that are related to synaptic/memory-, energy metabolism-, intracellular transport-, cell cycle-, cellular defense and structure, and stress response. To further verify the target proteins that may underlie the memory deficits, we pre-treated the 3xTg-AD mice for 3 months with coenzyme Q10 (CoQ10) (800 mg/kg body weight/day), a powerful endogenous antioxidant that has been shown to be able to prevent memory deficits in several AD mouse models. We found that administration of CoQ10 altered the expression levels of nine proteins in hippocampus of 3xTg-AD mice with simultaneous improvement of spatial memory. Interestingly, complexin-1/2, two molecules which were shown to alter LTP, were modulated (i.e., the levels were reduced in 3xTg-AD mice and CoQ10 restored the levels) in response to CoQ10 treatment among these nine proteins. Furthermore, we found that adeno-associated virus serotype 9 (AAV-9)-mediated overexpression of complexin-1/2 prevented memory impairment in the AD mouse model. Taken together, this study has identified a number of differentially expressed proteins in hippocampus of 3xTg-AD mice and the control in presence or absence of CoQ10. The modulation of complexin-1/2 expression by CoQ10 may contribute to the amelioration of memory impairment in the AD transgenic mice.

Entities:  

Keywords:  Adeno-associated virus; Alzheimer’s disease; Memory; Proteomic analysis; Triple (PS1M146V/APPSwe/TauP301L) transgenic mice

Mesh:

Substances:

Year:  2016        PMID: 27335030     DOI: 10.1007/s12035-016-9959-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  35 in total

Review 1.  Alzheimer's disease: from molecular biology to neuropsychiatry.

Authors:  Jeffrey L Cummings
Journal:  Semin Clin Neuropsychiatry       Date:  2003-01

Review 2.  Alzheimer's disease.

Authors:  Jeffrey L Cummings
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

3.  Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.

Authors:  Renã A S Robinson; Gururaj Joshi; Quanzhen Huang; Rukhsana Sultana; Austin S Baker; Jian Cai; William Pierce; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  Proteomics       Date:  2011-09-22       Impact factor: 3.984

4.  Protein quality control: chaperones culling corrupt conformations.

Authors:  Amie J McClellan; Stephen Tam; Daniel Kaganovich; Judith Frydman
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

5.  Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

Authors:  Maurice W Dysken; Mary Sano; Sanjay Asthana; Julia E Vertrees; Muralidhar Pallaki; Maria Llorente; Susan Love; Gerard D Schellenberg; J Riley McCarten; Julie Malphurs; Susana Prieto; Peijun Chen; David J Loreck; George Trapp; Rajbir S Bakshi; Jacobo E Mintzer; Judith L Heidebrink; Ana Vidal-Cardona; Lillian M Arroyo; Angel R Cruz; Sally Zachariah; Neil W Kowall; Mohit P Chopra; Suzanne Craft; Stephen Thielke; Carolyn L Turvey; Catherine Woodman; Kimberly A Monnell; Kimberly Gordon; Julie Tomaska; Yoav Segal; Peter N Peduzzi; Peter D Guarino
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

Review 6.  Evolution of carbohydrate metabolic pathways.

Authors:  A H Romano; T Conway
Journal:  Res Microbiol       Date:  1996 Jul-Sep       Impact factor: 3.992

7.  Evolutionary conservation of protein regions in the protonmotive cytochrome b and their possible roles in redox catalysis.

Authors:  N Howell
Journal:  J Mol Evol       Date:  1989-08       Impact factor: 2.395

Review 8.  Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Authors:  Vittorio Calabrese; Raffaele Lodi; Caterina Tonon; Velia D'Agata; Maria Sapienza; Giovanni Scapagnini; Andrea Mangiameli; Giovanni Pennisi; A M Giuffrida Stella; D Allan Butterfield
Journal:  J Neurol Sci       Date:  2005-06-15       Impact factor: 3.181

9.  Differential mechanisms of opioidergic and dopaminergic systems of the ventral hippocampus (CA₃) in anxiolytic-like behaviors induced by cholestasis in mice.

Authors:  Mohammad Nasehi; Faezeh Kafi; Mohammad-Reza Zarrindast
Journal:  Eur J Pharmacol       Date:  2013-07-20       Impact factor: 4.432

10.  Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging.

Authors:  Alexei A Podtelezhnikov; Keith Q Tanis; Michael Nebozhyn; William J Ray; David J Stone; Andrey P Loboda
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

View more
  5 in total

Review 1.  Coenzyme Q10 a mitochondrial restorer for various brain disorders.

Authors:  Nilima Pradhan; Charan Singh; Arti Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-10-01       Impact factor: 3.195

2.  Role of Kalirin and mouse strain in retention of spatial memory training in an Alzheimer's disease model mouse line.

Authors:  Lillian Russo-Savage; Vishwanatha K S Rao; Betty A Eipper; Richard E Mains
Journal:  Neurobiol Aging       Date:  2020-07-14       Impact factor: 4.673

3.  Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease.

Authors:  Haitao Yu; Xuemei Lin; Dian Wang; Zaijun Zhang; Yi Guo; Xiaohu Ren; Benhong Xu; Jianhui Yuan; Jianjun Liu; Peter S Spencer; Jian-Zhi Wang; Xifei Yang
Journal:  Front Mol Neurosci       Date:  2018-03-09       Impact factor: 5.639

Review 4.  Dissecting Endoplasmic Reticulum Unfolded Protein Response (UPRER) in Managing Clandestine Modus Operandi of Alzheimer's Disease.

Authors:  Safikur Rahman; Ayyagari Archana; Arif Tasleem Jan; Rinki Minakshi
Journal:  Front Aging Neurosci       Date:  2018-02-06       Impact factor: 5.750

Review 5.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.